Back

Circulating galectin 1 is associated with severity of coronary artery disease and adverse cardiovascular events in patients undergoing coronary angiography

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 6 - Coronary artery disease inflammation Inflammation and Immunity ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Ruey-Hsing Chou

Taipei Veterans General Hospital, Taipei (Taiwan)

10 More presentations in this session

Presentation thumbnail
Inflammation implicated in the aetiology of major vascular and non-vascular diseases in East Asians
Doctor M. Karim (Oxford, GB)
Abstract Slides
Presentation thumbnail
Proprotein convertase subtilisin/kexin 9 (PCSK9) and lipopolysaccharide (LPS) in patients with atrial fibrillation. A biomarker post-hoc analysis from the ATHERO-AF cohort.
Professor P. Pignatelli Spinazzola (Rome, IT)
Abstract Slides
Presentation thumbnail
Growth differentiation factor-15 and mortality in suspected or known coronary heart disease patients with chronic kidney disease: a subanalysis of the ANOX study
Doctor D. Takagi (Kyouto, JP)
Abstract
Presentation thumbnail
Impact of CD14++CD16+ monocytes on coronary plaque vulnerability assessed by optical coherence tomography in coronary artery disease patients
Doctor H. Yamamoto (Kobe, JP)
Abstract Slides
Presentation thumbnail
Apabetalone (RVX-208) inhibits key drivers of vascular inflammation, calcification, and plaque vulnerability through a BET-dependent epigenetic mechanism
Doctor E. Kulikowski (Calgary, CA)
Abstract

Access the full session

Session thumbnail
Poster Session 6 - Coronary artery disease inflammation

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources